MARKET

STIM

STIM

Neuronetics
NASDAQ
4.860
-0.080
-1.62%
After Hours: 4.849 -0.011 -0.23% 16:34 03/21 EDT
OPEN
4.920
PREV CLOSE
4.940
HIGH
4.920
LOW
4.770
VOLUME
408.57K
TURNOVER
--
52 WEEK HIGH
5.92
52 WEEK LOW
0.5200
MARKET CAP
309.35M
P/E (TTM)
-3.5576
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STIM last week (0310-0314)?
Weekly Report · 4d ago
Weekly Report: what happened at STIM last week (0303-0307)?
Weekly Report · 03/10 10:07
BUZZ-Cooper Companies falls to 15-month low on Q1 revenue miss
Reuters · 03/07 15:02
Neuronetics’ Earnings Call: Growth Amid Challenges
TipRanks · 03/06 00:32
Neuronetics Price Target Raised to $8.00/Share From $5.00 by Canaccord Genuity
Dow Jones · 03/05 21:31
Neuronetics Is Maintained at Buy by Canaccord Genuity
Dow Jones · 03/05 21:31
Canaccord Genuity Maintains Buy on Neuronetics, Raises Price Target to $8
Benzinga · 03/05 21:21
Neuronetics Price Target Raised to $7.00/Share From $3.00 by Citizens Capital Markets
Dow Jones · 03/05 15:32
More
About STIM
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.